Revenue
2019
2021
2022
2023
2024
2025
Strata Critical Medical, Inc. (SRTA)
Price—Loading quote
Net income
2019
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 · Dec 31 | 2019 · Sep 30 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $197.1M | $146.8M | $225.2M | $146.1M | $50.5M | — | — | $31.2M |
| Gross profit | $41.1M | $29.6M | — | — | — | — | — | — |
| Operating expenses | $63.5M | $52.1M | — | — | — | $678,487 | — | — |
| Operating income | −$22.4M | −$22.5M | −$68.1M | −$53.5M | −$24.1M | −$678,487 | — | −$11.5M |
| EBITDAderived | −$14.2M | −$16.6M | −$61.0M | −$47.8M | −$23.5M | — | — | −$11.1M |
| Net income | $41.3M | −$27.3M | −$56.1M | −$27.3M | −$40.1M | −$20.5M | $2.3M | −$10.8M |
| Basic EPSper diluted share | $0.50 | -$0.35 | -$0.76 | -$0.38 | -$0.93 | -$2.17 | $0.19 | -$0.43 |
| Diluted EPSper diluted share | $0.50 | -$0.35 | -$0.76 | -$0.38 | -$0.93 | -$2.17 | $0.19 | -$0.43 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 8, 2026Form 4 | Heyburn William A.Co-CEO and CFO | SellClass A common stock, $0.0001 par value per share | 31.7K | $5.87 | $185.9K | 1.55M |
| Jun 8, 2026Form 4 | Cohen AmirChief Accounting Officer | SellClass A common stock, $0.0001 par value per share | 4.7K | $5.87 | $27.3K | 146.6K |
| Jun 8, 2026Form 4 | Tomkiel Melissa M.Co-CEO and General Counsel | SellClass A common stock, $0.0001 par value per share | 29.7K | $5.87 | $174.5K | 1.89M |
| Jun 8, 2026Form 4 | Wunsch Scott MCEO, Logistics | SellClass A common stock, $0.0001 par value per share | 5.5K | $5.87 | $32.6K | 625.6K |
| May 22, 2026Form 4 · 10b5-1 | Cohen AmirChief Accounting Officer | SellClass A common stock, $0.0001 par value per share | 40.6K | $5.91 | $239.8K | 151.3K |